CN1037104C - 新型环孢多肽 - Google Patents

新型环孢多肽 Download PDF

Info

Publication number
CN1037104C
CN1037104C CN93102101A CN93102101A CN1037104C CN 1037104 C CN1037104 C CN 1037104C CN 93102101 A CN93102101 A CN 93102101A CN 93102101 A CN93102101 A CN 93102101A CN 1037104 C CN1037104 C CN 1037104C
Authority
CN
China
Prior art keywords
formula
cyclosporins
cyclosporine
ser
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN93102101A
Other languages
English (en)
Chinese (zh)
Other versions
CN1076453A (zh
Inventor
J·J·波尔斯特里
M·K·艾伯勒
R·内夫
T·G·佩恩
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of CN1076453A publication Critical patent/CN1076453A/zh
Application granted granted Critical
Publication of CN1037104C publication Critical patent/CN1037104C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C07K7/645—Cyclosporins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Gasification And Melting Of Waste (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CN93102101A 1992-03-02 1993-03-01 新型环孢多肽 Expired - Fee Related CN1037104C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9204466.8 1992-03-02
GB929204466A GB9204466D0 (en) 1992-03-02 1992-03-02 Improvements in or relating to organic compounds

Publications (2)

Publication Number Publication Date
CN1076453A CN1076453A (zh) 1993-09-22
CN1037104C true CN1037104C (zh) 1998-01-21

Family

ID=10711333

Family Applications (1)

Application Number Title Priority Date Filing Date
CN93102101A Expired - Fee Related CN1037104C (zh) 1992-03-02 1993-03-01 新型环孢多肽

Country Status (26)

Country Link
US (1) US5643870A (OSRAM)
EP (1) EP0577544B1 (OSRAM)
JP (1) JP3382656B2 (OSRAM)
KR (1) KR100256988B1 (OSRAM)
CN (1) CN1037104C (OSRAM)
AT (1) ATE146484T1 (OSRAM)
AU (1) AU667072B2 (OSRAM)
CA (1) CA2090634C (OSRAM)
CZ (1) CZ285421B6 (OSRAM)
DE (1) DE69306670T2 (OSRAM)
DK (1) DK0577544T3 (OSRAM)
ES (1) ES2096262T3 (OSRAM)
FI (1) FI111729B (OSRAM)
GB (1) GB9204466D0 (OSRAM)
GR (1) GR3022539T3 (OSRAM)
HU (1) HU214028B (OSRAM)
IL (1) IL104891A (OSRAM)
MX (1) MX9301129A (OSRAM)
MY (1) MY106921A (OSRAM)
NO (1) NO310685B1 (OSRAM)
NZ (1) NZ247031A (OSRAM)
PL (1) PL174816B1 (OSRAM)
RU (1) RU2131883C1 (OSRAM)
SK (1) SK279529B6 (OSRAM)
TW (1) TW264472B (OSRAM)
ZA (1) ZA931491B (OSRAM)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639852A (en) * 1994-09-01 1997-06-17 Wisconsin Alumni Research Foundation Immunostimulatory agents
CN1130373C (zh) * 1996-09-13 2003-12-10 诺瓦蒂斯有限公司 [3'－脱氧－3'－氧代－MeBmt]'环孢菌素制备方法
ZA9711732B (en) 1996-12-31 1998-12-28 Quadrant Holdings Cambridge Methods and compositions for improvement bioavailability of bioactive agents for mucosal delivery
US20030220234A1 (en) 1998-11-02 2003-11-27 Selvaraj Naicker Deuterated cyclosporine analogs and their use as immunodulating agents
DE69840586D1 (de) 1997-10-08 2009-04-02 Isotechnika Inc Deuterierte Cyclosporin-analoga und ihre Verwendung als immunmodulierende Agenzien
RU2235554C2 (ru) * 1998-03-06 2004-09-10 Новартис Аг Предварительно приготовленные эмульсионные концентраты, содержащие циклоспорин или макролид
US6784156B2 (en) * 2001-03-05 2004-08-31 Enanta Pharmaceuticals, Inc. Cyclosporins for the treatment of respiratory diseases
US6995139B2 (en) * 2001-04-20 2006-02-07 Debiopharm S.A. Cyclic undecapeptide pro-drugs and uses thereof
US20030087813A1 (en) * 2001-10-12 2003-05-08 Or Yat Sun Cyclosporin analogs for the treatment of lung diseases
US6809077B2 (en) * 2001-10-12 2004-10-26 Enanta Pharmaceuticals, Inc. Cyclosporin analogs for the treatment of autoimmune diseases
RU2321593C9 (ru) 2001-10-19 2008-06-20 Изотехника Инк. Синтез аналогов циклоспорина
ATE401339T1 (de) * 2001-10-19 2008-08-15 Isotechnika Inc Mischungen von cyclosporin-analogen und ihre verwendung als immunmodulatoren
US7012065B2 (en) 2003-02-07 2006-03-14 Enanta Pharmaceuticals, Inc. Cyclosporins for the treatment of immune disorders
JP2006524232A (ja) * 2003-03-17 2006-10-26 アルバニー モレキュラー リサーチ インコーポレーティッド 新規サイクロスポリン
US20040266669A1 (en) * 2003-06-20 2004-12-30 Wu Frank X. H. Cyclosporin derivatives for the treatment of immune disorders
JP2006014722A (ja) 2004-06-02 2006-01-19 Keio Gijuku 遺伝子マーカー及びその利用
WO2006039164A2 (en) * 2004-09-29 2006-04-13 Amr Technology, Inc. Novel cyclosporin analogues and their pharmaceutical uses
EP1809656A4 (en) * 2004-09-29 2009-03-25 Amr Technology Inc CYCLOSPORINAL KINANALOGA AND ITS PHARMACEUTICAL APPLICATIONS
US7361636B2 (en) * 2004-10-06 2008-04-22 Amr Technology, Inc. Cyclosporin alkynes and their utility as pharmaceutical agents
DE602005010607D1 (de) * 2004-11-22 2008-12-04 Astellas Pharma Inc Zyklosporinanalog
US7696166B2 (en) * 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne/alkene analogues for preventing or treating viral-induced disorders
US7696165B2 (en) * 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne analogues for preventing or treating viral-induced disorders
JP5668476B2 (ja) 2007-10-08 2015-02-12 オーリニア・ファーマシューティカルズ・インコーポレイテッドＡｕｒｉｎｉａ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃ． カルシニューリン阻害剤またはｍＴＯＲ阻害剤を含む眼科用組成物
JP5726733B2 (ja) * 2008-07-30 2015-06-03 シクロフィリン ファーマシューティカルズ コープ． 非免疫抑制性シクロスポリン類似体分子
WO2010144194A1 (en) 2009-06-09 2010-12-16 Lux Biosciences, Inc. Topical drug delivery systems for ophthalmic use
WO2012037485A2 (en) * 2010-09-16 2012-03-22 1The Johns Hopkins University Methods of inhibiting alphavirus replication and treating alphavirus infection
HRP20190096T1 (hr) 2010-12-15 2019-02-22 Contravir Pharmaceuticals, Inc. Molekule analoga ciklosporina modificirani na amino kiselini 1 i 3
CN105076117B (zh) * 2014-10-31 2017-08-25 北京林业大学 一种种子抗老化剂及其制备方法
KR20170000243U (ko) 2015-07-09 2017-01-18 (주)하나피앤씨 배관연결용 플랜지 기구
US9981041B2 (en) * 2016-08-23 2018-05-29 Ira Jason Salzman Ophthalmic lubricating spray
US20190224275A1 (en) 2017-05-12 2019-07-25 Aurinia Pharmaceuticals Inc. Protocol for treatment of lupus nephritis

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0414632A2 (en) * 1989-07-24 1991-02-27 Sandoz Ltd. Cyclosporin derivatives

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2819094A1 (de) * 1977-05-10 1978-11-23 Sandoz Ag Cyclosporin-derivate, ihre verwendung und herstellung
EP0194972B1 (en) * 1985-03-11 1992-07-29 Sandoz Ag Novel cyclosporins
US4649047A (en) * 1985-03-19 1987-03-10 University Of Georgia Research Foundation, Inc. Ophthalmic treatment by topical administration of cyclosporin
US4764503A (en) * 1986-11-19 1988-08-16 Sandoz Ltd. Novel cyclosporins
EP0283801A3 (en) * 1987-03-27 1990-05-30 Abbott Laboratories Fluorescence polarization assay for cyclosporin a and metabolites and related immunogens and antibodies
US4798823A (en) * 1987-06-03 1989-01-17 Merck & Co., Inc. New cyclosporin analogs with modified "C-9 amino acids"
DE3884470T2 (de) * 1987-06-17 1994-03-10 Sandoz Ag Cyclosporine und deren Benutzung als Arzneimittel.
GB8717300D0 (en) * 1987-07-22 1987-08-26 Nat Res Dev Cyclosporins
US4839342A (en) * 1987-09-03 1989-06-13 University Of Georgia Research Foundation, Inc. Method of increasing tear production by topical administration of cyclosporin
DE3840354A1 (de) * 1988-11-30 1990-06-07 Hoechst Ag Benzolsulfonamid-derivate und verfahren zu ihrer herstellung
AU4958590A (en) * 1988-12-05 1990-07-10 Trustees Of Columbia University In The City Of New York, The Novel derivatives of cyclosporine a, antibodies directed thereto and uses thereof
US4996193A (en) * 1989-03-03 1991-02-26 The Regents Of The University Of California Combined topical and systemic method of administration of cyclosporine
US5202310A (en) * 1990-06-06 1993-04-13 Levy Gary A Cyclosporine metabolites
DE69124459T3 (de) * 1990-11-02 2001-05-31 Novartis Ag, Basel Zyklosporine

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0414632A2 (en) * 1989-07-24 1991-02-27 Sandoz Ltd. Cyclosporin derivatives

Also Published As

Publication number Publication date
HUT64567A (en) 1994-01-28
GB9204466D0 (en) 1992-04-15
NO310685B1 (no) 2001-08-13
TW264472B (OSRAM) 1995-12-01
CZ30393A3 (en) 1994-02-16
GR3022539T3 (en) 1997-05-31
FI930912L (fi) 1993-09-03
DE69306670D1 (de) 1997-01-30
ES2096262T3 (es) 1997-03-01
DE69306670T2 (de) 1997-07-03
EP0577544B1 (en) 1996-12-18
CA2090634A1 (en) 1993-09-03
RU2131883C1 (ru) 1999-06-20
US5643870A (en) 1997-07-01
ATE146484T1 (de) 1997-01-15
NO930738L (no) 1993-09-03
EP0577544A1 (en) 1994-01-05
KR930019692A (ko) 1993-10-18
PL297902A1 (en) 1993-09-06
CN1076453A (zh) 1993-09-22
MX9301129A (es) 1994-07-29
FI111729B (fi) 2003-09-15
FI930912A0 (fi) 1993-03-01
PL174816B1 (pl) 1998-09-30
HU9300418D0 (en) 1993-05-28
JPH07252296A (ja) 1995-10-03
SK279529B6 (sk) 1998-12-02
ZA931491B (en) 1994-09-02
IL104891A0 (en) 1993-07-08
DK0577544T3 (da) 1997-04-01
HU214028B (en) 1997-12-29
IL104891A (en) 1997-04-15
SK14093A3 (en) 1993-10-06
NO930738D0 (no) 1993-03-01
KR100256988B1 (ko) 2000-05-15
CA2090634C (en) 2005-12-13
MY106921A (en) 1995-08-30
JP3382656B2 (ja) 2003-03-04
NZ247031A (en) 1995-05-26
AU3387293A (en) 1993-09-09
AU667072B2 (en) 1996-03-07
CZ285421B6 (cs) 1999-08-11

Similar Documents

Publication Publication Date Title
CN1037104C (zh) 新型环孢多肽
JP5272140B2 (ja) シクロスポリン類似体混合物及びそれらの免疫調節剤としての使用
JP2772372B2 (ja) シクロスポリン類およびそれらの医薬用途
CN1218958C (zh) 活性范围改善的环孢菌素
US6784156B2 (en) Cyclosporins for the treatment of respiratory diseases
CN103153330A (zh) 新的环孢霉素衍生物在病毒感染的治疗和预防中的应用
JPS60215700A (ja) 新規シクロスポリン類
AU2006259604A1 (en) Substituted phenylphosphates as mutual prodrugs of steroids and beta -agonists for the treatment of pulmonary inflammation and bronchoconstriction
US20100256074A1 (en) Processes for preparing high purity aza cyclohexapeptides
KR100201174B1 (ko) 사이클로스포린 유도체
EP0373260B1 (en) Cyclosporin derivatives with modified "8-amino acid"
JPH02145599A (ja) 生物学的に活性なリポタンパク質およびその使用
JP4544746B2 (ja) 置換された１，３−ジアリール−２−ピリド−２−イル−３−（ピリド−２−イルアミノ）プロパノール誘導体、その製造方法、それを含有する医薬およびその使用
JP4619592B2 (ja) エキノカンジンの新誘導体、それらの製造方法及びそれらの抗菌剤としての使用
JPS6245846B2 (OSRAM)
TW202525273A (zh) 一種glp-1受體化合物及其製備方法與應用
JPS6299397A (ja) 高活性のゴナドリベリン類似体
AU2002245567A1 (en) Cyclosporins for the treatment of respiratory diseases

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C53 Correction of patent of invention or patent application
COR Change of bibliographic data

Free format text: CORRECT: PATENTEE; FROM: SANDOZ CO., LTD. TO: NOVARTIS CO., LTD.

CP01 Change in the name or title of a patent holder

Patentee after: Novartis AG

Patentee before: Sandoz Ltd.

C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 19980121

Termination date: 20100301